, Tracking Stock Market Picks
Enter Symbol:
Sciclone Pharmaceuticals, Inc. (SCLN) [hlAlert]

up 76.33 %

Sciclone Pharmaceuticals, Inc. (SCLN) downgraded to Hold with price target $8 by BWS Financial

Posted on: Friday,  Nov 14, 2014  12:25 PM ET by BWS Financial

BWS Financial rated Hold Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) on 11/14/2014. Previously BWS Financial rated Buy Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) on
09/18/2012., when the stock price was $4.86. Since then, Sciclone Pharmaceuticals, Inc. has gained 76.34% as of 11/14/2014's recent price of $8.57.
If you would have followed the previous BWS Financial's recommendation on SCLN, you would have gained 76.33% of your investment in 787 days.

Sciclone Pharmaceuticals, Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. They have focused their current product development and commercial activities on the following diseases: hepatitis C, hepatocellular carcinoma, malignant melanoma, hepatitis B, HIV, drug-resistant tuberculosis, cystic fibrosis and others.

· BWS Financial is a Los Angeles based independent stock research firm, which focuses primarily on undervalued companies with little or no street coverage, within the biotechnology, healthcare and technology industries. · BWS Financial focuses on companies that hold much potential in their industries, either through their product pipeline or technological innovations. · BWS Financial’s strategy is not to only specialize in a particular group of stocks, but to also provide investors with insight into other ideas where there is considerable misvaluation.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/14/2014 12:25 PM Hold
8.57 8.00
as of 10/17/2014
1 Week up  11.83 %
1 Month up  9.92 %
3 Months up  62.13 %
1 YTD up  53.76 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/18/2012 10:25 AM Buy
4.86 8.25
8/10/2010 9:25 AM Hold
2.58 4.50
4/9/2010 9:25 AM Buy
3.96 7.25
7/8/2009 8:25 AM Hold
2.70 3.25

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy